DaVita
DVA
#2385
Rank
C$10.64 B
Marketcap
C$148.84
Share price
1.96%
Change (1 day)
-41.81%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): C$13.99

According to DaVita's latest financial reports the company's current EPS (TTM) is C$13.53. In 2024 the company made an earnings per share (EPS) of C$15.02 an increase over its 2023 EPS that were of C$10.36.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$13.99-6.84%
2024C$15.0244.94%
2023C$10.3627.26%
2022C$8.14-35.56%
2021C$12.6344.1%
2020C$8.7719.7%
2019C$7.32540.48%
2018C$1.14-76.07%
2017C$4.78-19.31%
2016C$5.92242.52%
2015C$1.73-62.87%
2014C$4.6613.43%
2013C$4.108.45%
2012C$3.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$29.06 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$13.95 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$20.01 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.58-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA